Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 48 | 54 | 99 | 122 | 110 |
| Cost of Goods | 29 | 57 | 34 | 47 | 51 |
| Gross Profit | 19 | -3 | 65 | 76 | 59 |
| Operating Expenses | 428 | 520 | 455 | 413 | 460 |
| Operating Income | -379 | -466 | -356 | -291 | -350 |
| Interest Expense | 100 | 117 | 119 | 107 | 98 |
| Other Income | 20 | 94 | -49 | 767 | -957 |
| Pre-tax Income | -460 | -489 | -524 | 370 | -1,405 |
| Net Income Continuous | -460 | -489 | -524 | 370 | -1,405 |
| Net Income | $-460 | $-489 | $-524 | $370 | $-1,405 |
| EBITDA(a) | $-315 | $-361 | $-249 | $-200 | $-268 |